Company

Valthos

Next-generation biodefense company building AI-powered software infrastructure to detect biological threats and rapidly design countermeasures.

Defense & Aerospace

People

Kathleen McMahonco-founder

Funding History

Valthos raised $30M emerging from stealth. Founders Fund and Lux Capital were early backers; OpenAI's startup fund joined to help lead the round.

Investors

Founders Fund Lux Capital OpenAILead

News

Interviews (2)

Valthos raises $30M from Founders Fund, Lux Capital, and OpenAI to build AI-powered biodefense infrastructure

Ex-Palantir life sciences lead Kathleen McMahon on the rising bioterrorism threat and AI-accelerated bioweapon uplift